Viewing StudyNCT00343109



Ignite Creation Date: 2024-05-05 @ 4:55 PM
Last Modification Date: 2024-10-26 @ 9:25 AM
Study NCT ID: NCT00343109
Status: COMPLETED
Last Update Posted: 2020-02-12
First Post: 2006-06-20

Brief Title: Vaccine Therapy in Treating Patients Receiving Trastuzumab For HER2-Positive Stage IIIB-IV Breast Cancer
Sponsor: University of Washington
Organization: University of Washington

Key Dates - Follows AllAPIJSON File Order

Start Date: 2004-03
Start Date Type: None
Primary Completion Date: 2015-06
Primary Completion Date Type: ACTUAL
Completion Date: None
Completion Date Type: None
First Submit Date: 2006-06-20
First Submit QC Date: June 20 2006
Study First Post Date: 2006-06-22
Study First Post Date Type: ESTIMATED
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: 2017-04-03
Disp First Submit QC Date: April 3 2017
Disp First Post Date: 2017-04-05
Disp First Post Date Type: ACTUAL
Last Update Submit Date: 2020-02-07
Last Update Post Date: 2020-02-12
Last Update Post Date Type: ACTUAL